TrialBMC cancer2018

Barrett's oESophagus trial 3 (BEST3): study protocol for a randomised controlled trial comparing the Cytosponge-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care patients with chronic acid reflux.

Judith Offman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.